MYBPC3 and cardiomyopathy: Lee et al. demonstrated in the multicenter registry The Sarcomeric Human Cardiomyopathy Registry (SHaRe) that among patients with coexisting MYH7, MYBPC3, and thin filament mutations, the MYH7 mutation group showed the highest incidence of AF, even after adjusting for LA size.